Salicylic acid is the most requested BHA and the one most often described inaccurately in a product brief. It is not a liquid acid that can be poured into water — it is a crystalline solid with very limited water solubility, and that single physical fact determines the format, the carrier and the processing long before the pH discussion starts.
Two briefs that both say "2% salicylic acid serum" can produce two products that behave completely differently, because one formulator dissolved the material in a glycol system and the other suspended it. This article is about making that choice deliberately.
Solubility decides the format before pH does
The starting point is the material's behaviour in water. Salicylic acid dissolves only sparingly in pure water, and the solubility that does exist is largely a function of the salt form rather than the acid form.
That creates an immediate tension. The free acid is the form with the useful role; the dissolved form is often the salt. Getting a meaningful level of the material into a clear aqueous product means adding something that improves solubility, and whatever you add changes the product.
So the sequence is: decide the level, decide the solubility route, and only then set the pH. A formulator who starts with pH is working from the wrong end.
The solubility routes, and what each costs you
Three routes are used in practice, and each has a visible consequence:
- Glycols and polyols. Propylene glycol, butylene glycol and similar materials improve solubility substantially and are the most common route in a serum. The cost is sensory: a high glycol load feels warmer and slightly tacky on application, and it changes how the base behaves at low temperature.
- Ethanol. Solubility improves sharply with alcohol, and a hydro-alcoholic base gives a light, fast-drying product. The cost is the drying sensation and, in some markets, labelling and transport considerations around the alcohol content.
- Surfactant solubilisation. A surfactant system can hold the material in a clear product without a high glycol load. The cost is that the formula now contains a surfactant at a level that changes the skin feel and, if the level is high enough, moves the product towards a cleansing format rather than a leave-on serum.
There is a fourth option, which is not to dissolve it at all. A suspended or dispersed BHA product is perfectly workable — it just has a different sensory profile and needs a different stability study, because a suspension can settle. That route is discussed in our azelaic acid article, which faces the same powder problem.
pH, pKa and free acid
Once the material is in solution, the free acid calculation applies in exactly the form it takes for the AHAs: the fraction of the material present in the undissociated form depends on the pH relative to the acid's pKa, and it is that fraction which constitutes the useful dose.
The practical consequences are the same as for any acid:
- Below the pKa, most of the material is undissociated and the product is at its most active.
- At the pKa, roughly half is undissociated.
- Well above the pKa, very little is undissociated, and the product behaves like a salt solution with the acid named on the label.
The difference between a product at a moderately acidic pH and one nearer neutral is therefore large, and it is not visible on the front of the pack. Our AHA article works through the arithmetic in detail; the same relationship applies here.
What the market limits actually restrict
Most markets place conditions on leave-on products containing this ingredient. Typically those conditions combine a maximum concentration with a minimum age for use, and some markets require a specific warning on the pack.
The conditions differ between markets, and the definitions differ too — a rinse-off product and a leave-on product are frequently treated differently, as are products intended for children. Because the thresholds and the definitions both vary, the target market has to be settled before the formula is designed rather than after.
One practical warning: the same percentage can be acceptable in one market and not in another, and the fix is a reformulation rather than a labelling change. Our reformulation article covers what changing markets after the fact involves, and our blemish-prone skin article covers how the claim and the concentration interact.
Why the format follows solubility
The solubility constraint explains why BHA products cluster into a few formats:
- Aqueous gel or serum with a glycol load. The most common. Clear, easy to apply, and the glycol is what makes the level achievable.
- Hydro-alcoholic toner or liquid. Higher solubility, faster drying, stronger sensory signal. Common in cleansing pads and toners.
- Anhydrous or capsule fill. Avoids water entirely and sidesteps the solubility question, but then the material has to be handled as a dispersion and the fill has to be uniform. See our fill weight article.
- Rinse-off cleanser. A much easier formulation problem, and a different consumer proposition.
Concentration versus free acid: the number to specify
The label percentage is the input. The free acid value is the dose. A specification that names only the percentage leaves the most important variable to the manufacturer, and two suppliers given the same percentage can deliver products with measurably different behaviour.
So the specification should carry both: the as-supplied level of the material, and the pH the finished product must sit at. If you want to be thorough, ask for the free acid value to be reported as a calculated number at release and at each stability point, because pH drift is the failure mode that quietly changes the dose.
The same discipline applies to the glycol or alcohol level, since that is what makes the concentration achievable in the first place. A product that meets the percentage on the pack but needed a much higher glycol load than expected is a different product from the one that was briefed.
Solubility routes compared
| Route | Level achievable | Sensory cost | Other consequences |
|---|---|---|---|
| Glycol / polyol | Moderate to high | Warmer feel, some tack | Cold-temperature behaviour changes |
| Ethanol | High | Drying, fast set | Labelling and transport considerations |
| Surfactant solubilisation | Moderate | Lighter but less cushioning | Moves the product towards a cleansing format |
| Suspension / dispersion | Depends on particle size | Can feel gritty if coarse | Needs a settling and re-dispersion study |
Stability, colour and the chelation question
The material is not especially light-sensitive in a formulated product, but two stability points are worth planning for.
The first is pH drift, which matters more here than in most formulas because the dose depends on it. The second is the suspension case — a dispersed product needs a settling study and a clear instruction on the pack about shaking, and a product that separates without telling the customer will be returned.
The chelation question is a formulation detail with a chemical basis. Salicylic acid binds metal ions, and a chelating agent in the same formula competes for them. The practical consequence is that a chelator added for colour stability can reduce the availability of the active, in the same way that a chelator strips the copper out of a copper peptide — see our peptide article for that parallel. The test is an assay on the finished product, not an assumption.
Preservation also deserves attention, because the glycol and alcohol loads that carry the active are not a substitute for a tested preservative system — see our preservative article.
Claim boundaries
The available claims are appearance and feel claims: skin looks clearer and more even, the surface looks refined, pores look less visible, and the skin feels smoother.
What is not available is any statement about treating a skin condition, about reducing inflammation, or about the product being a treatment. The blemish-prone category is where this boundary is tested most often, and it is covered in our dedicated article. Our efficacy testing article covers how the permitted versions are substantiated.
Testing to commission
- Assay on the active at release and at each stability point, so the dose is known rather than assumed.
- pH at release and across stability, reported as a number rather than a range that hides the drift.
- Settling and re-dispersion study if the product is a suspension.
- Preservative efficacy on the finished formula at its actual pH.
- Pack compatibility where the formula is acidic and any component is metallic — see our packaging article.
- Consumer use test capturing the sensation, since that is what drives returns in this category.
Where our capability fits
We formulate BHA systems with the solubility route and the pH specified together, in aqueous glycol bases, hydro-alcoholic toners and capsule fills. Examples include a custom cosmetic softgel face serum capsule and a facial essence capsule.
We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing, and full custom formula development — whichever matches where your brand is today.
Tell us the market, the format and the sensation you are prepared to stand behind, and we will come back with the carrier system and the pH. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319.
General manufacturing information, not regulatory or legal advice. Concentration limits and labelling requirements vary by market.